Efficacy of mycophenolate mofetil in pediatric patients with steroid-dependent nephrotic syndrome

Pediatric Nephrology

Volumn 20, Issue 9, 2005, Pages 1265-1268

  Novak, Inna ^a   Frank, Rachel ^a   Vento, Suzanne ^a   Vergara, Marcela ^a   Gauthier, Bernard ^a   Trachtman, Howard ^a  

^a SCHNEIDER CHILDREN'S HOSPITAL   (United States)

Author keywords

Mycophenolate mofetil; Nephrotic syndrome; Steroid dependent

Indexed keywords

ANTIHYPERTENSIVE AGENT; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FUROSEMIDE; LEVAMISOLE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS;

ADOLESCENT; ARTICLE; CHICKENPOX; CHILD; CHILD CARE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INDICATION; DRUG RESPONSE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EDEMA; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INFANT; LABORATORY TEST; MALE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY;

ADOLESCENT; ADRENAL CORTEX HORMONES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE; MYCOPHENOLIC ACID; NEPHROSIS, LIPOID; PREDNISONE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 24044491584     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-005-1957-y     Document Type: Article

References (8)

1. International Study of Kidney Disease in Children (1978) Nephrotic syndrome in children: Prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children. Kidney Int 13:159-165 713276
2. Tarshish P, Tobin JN, Bernstein J, Edelmann CM Jr (1997) Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children. J Am Soc Nephrol 8:769-776 769-776 1:STN:280:ByiA3Mbps1Q%3D
3. Schwarz A (2001) New aspects of the treatment of nephrotic syndrome. J Am Soc Nephrol 12 [Suppl 17]:S44-47
4. Allison A, Eugui E (1993) Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil. Immunol Rev 125:5-28
5. Halloran P (1997) Mycophenolate mofetil in renal allograft recipients: A pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. Transplantation 63:39-47 10.1097/ 00007890-199701150-00008
6. Barletta GM, Smoyer WE, Bunchman TE, Flynn JT, Kershaw DB (2003) Use of mycophenolate mofetil in steroid dependent and resistant nephritic syndrome. Pediatr Nephrol 18:833-837 10.1007/s00467-003-1175-4
7. Bagga A, Hari P, Moudgil A, Jordan SC (2003) Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome. Am J Kidney Dis 42 1114-1120 10.1053/j.ajkd.2003.08.011
8. Stadermann MB, Lilien MR, van de Kar NCAJ, Monnens LAH, Schroder CH (2003) Is biopsy required prior to cyclophosphamide in steroid-sensitive nephrotic syndrome? Clin Nephrol 690:315-317